Fresenius SE & Co. KGaA (FSNUY)
13.04
+0.18
(+1.42%)
USD |
OTCM |
Oct 29, 16:00
Fresenius Enterprise Value : 41.77B for Oct. 29, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 29, 2026 | 41.77B |
| October 28, 2026 | 41.36B |
| October 27, 2026 | 41.25B |
| October 26, 2026 | 41.52B |
| October 23, 2026 | 41.41B |
| October 22, 2026 | 41.16B |
| October 21, 2026 | 41.36B |
| October 20, 2026 | 40.69B |
| October 19, 2026 | 40.91B |
| October 16, 2026 | 41.05B |
| October 15, 2026 | 40.49B |
| October 14, 2026 | 40.19B |
| October 13, 2026 | 39.61B |
| October 12, 2026 | 39.85B |
| October 09, 2026 | 39.38B |
| October 08, 2026 | 38.77B |
| October 07, 2026 | 39.85B |
| October 06, 2026 | 40.26B |
| October 05, 2026 | 40.40B |
| October 02, 2026 | 40.38B |
| October 01, 2026 | 40.44B |
| September 30, 2026 | 40.92B |
| September 29, 2026 | 40.82B |
| September 28, 2026 | 42.47B |
| September 25, 2026 | 42.31B |
| Date | Value |
|---|---|
| September 24, 2026 | 42.04B |
| September 23, 2026 | 42.18B |
| September 22, 2026 | 42.29B |
| September 21, 2026 | 41.88B |
| September 18, 2026 | 42.24B |
| September 17, 2026 | 42.26B |
| September 16, 2026 | 42.27B |
| September 15, 2026 | 41.97B |
| September 14, 2026 | 42.18B |
| September 11, 2026 | 41.88B |
| September 10, 2026 | 41.68B |
| September 09, 2026 | 41.50B |
| September 08, 2026 | 41.61B |
| September 04, 2026 | 41.05B |
| September 03, 2026 | 41.59B |
| September 02, 2026 | 41.61B |
| September 01, 2026 | 41.62B |
| August 31, 2026 | 42.11B |
| August 28, 2026 | 42.45B |
| August 27, 2026 | 42.60B |
| August 26, 2026 | 42.76B |
| August 25, 2026 | 42.56B |
| August 24, 2026 | 42.74B |
| August 21, 2026 | 43.12B |
| August 20, 2026 | 43.11B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Fresenius Medical Care AG | 24.75B |
| Exlites Holdings International, Inc. | 19.82M |
| Xcelerate, Inc. | 12.35M |
| Merck KGaA | 33.72B |
| Rafina Innovations, Inc. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 463.92M |
| Revenue (Quarterly) | 6.912B |
| Total Expenses (Quarterly) | 6.468B |
| EPS Diluted (Quarterly) | 0.1971 |
| Gross Profit Margin (Quarterly) | 26.07% |
| Profit Margin (Quarterly) | 6.71% |
| Earnings Yield | 6.04% |
| Operating Earnings Yield | 8.92% |
| Normalized Earnings Yield | 6.042 |